MNLO - Menlo Therapeutics EPS misses by $0.93 beats on revenue August, 06 2020 07:13 AM VYNE Therapeutics Menlo Therapeutics (NASDAQ:MNLO): Q2 GAAP EPS of -$1.21 misses by $0.93.Revenue of $11.7M beats by $9.66M.Shares -1.9% PM.Press ReleaseMore news on: Menlo Therapeutics Inc., Earnings news and commentary, Healthcare stocks news,